Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by STEVEN CURLEY and JEAN NICOLAS VAUTHEY.
STEVEN CURLEY
Connection Strength
5.515
JEAN NICOLAS VAUTHEY
  1. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg. 2004 May; 239(5):722-30; discussion 730-2.
    View in: PubMed
    Score: 0.251
  2. Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Rev. 2004 Jan-Jun; 23(1-2):165-82.
    View in: PubMed
    Score: 0.245
  3. Morbidity and mortality in 1,174 patients undergoing hepatic parenchymal transection using a stapler device. Ann Surg Oncol. 2014 Mar; 21(3):995-1001.
    View in: PubMed
    Score: 0.121
  4. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg. 2014 Jan; 18(1):45-51.
    View in: PubMed
    Score: 0.121
  5. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg. 2013 Oct; 258(4):619-26; discussion 626-7.
    View in: PubMed
    Score: 0.120
  6. Modified cisplatin/interferon a-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma. Cancer. 2013 Sep 15; 119(18):3334-42.
    View in: PubMed
    Score: 0.118
  7. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013 Jun; 257(6):1079-88.
    View in: PubMed
    Score: 0.118
  8. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol. 2013 Aug; 20(8):2493-500.
    View in: PubMed
    Score: 0.115
  9. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg. 2013 Feb; 216(2):201-9.
    View in: PubMed
    Score: 0.114
  10. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012 Dec 20; 30(36):4566-72.
    View in: PubMed
    Score: 0.113
  11. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Ann Surg. 2012 Oct; 256(4):642-50.
    View in: PubMed
    Score: 0.112
  12. Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections. J Gastrointest Surg. 2013 Jan; 17(1):57-64; discussion p.64-5.
    View in: PubMed
    Score: 0.112
  13. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins. J Gastrointest Surg. 2012 Sep; 16(9):1666-71.
    View in: PubMed
    Score: 0.111
  14. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery. 2012 May; 151(5):710-6.
    View in: PubMed
    Score: 0.107
  15. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford). 2011 Nov; 13(11):774-82.
    View in: PubMed
    Score: 0.104
  16. Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified? Cancer. 2011 Oct 01; 117(19):4484-92.
    View in: PubMed
    Score: 0.101
  17. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011 Mar 10; 29(8):1083-90.
    View in: PubMed
    Score: 0.100
  18. Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford). 2010 Aug; 12(6):427-33.
    View in: PubMed
    Score: 0.097
  19. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2010 Nov; 17(11):2870-6.
    View in: PubMed
    Score: 0.096
  20. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer. 2010 Apr 15; 116(8):1938-46.
    View in: PubMed
    Score: 0.095
  21. Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases. Arch Surg. 2010 Apr; 145(4):340-5; discussion 345.
    View in: PubMed
    Score: 0.094
  22. Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections. Surgery. 2010 Jan; 147(1):40-8.
    View in: PubMed
    Score: 0.091
  23. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. Surgery. 2009 Apr; 145(4):399-405.
    View in: PubMed
    Score: 0.088
  24. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008 Nov 20; 26(33):5344-51.
    View in: PubMed
    Score: 0.085
  25. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol. 2008 Nov; 15(11):3147-56.
    View in: PubMed
    Score: 0.085
  26. Re: Right hepatic trisectionectomy for hepatobiliary disease: results and an appraisal of its current role. Ann Surg. 2008 Jul; 248(1):138-9; author reply 139-40.
    View in: PubMed
    Score: 0.084
  27. Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol. 2008 Apr; 15(4):986-92.
    View in: PubMed
    Score: 0.081
  28. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer. 2007 Dec 15; 110(12):2761-7.
    View in: PubMed
    Score: 0.081
  29. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg. 2007 Jun; 193(6):702-6.
    View in: PubMed
    Score: 0.078
  30. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007 May; 204(5):854-62; discussion 862-4.
    View in: PubMed
    Score: 0.076
  31. Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg. 2007 Jan; 11(1):66-72.
    View in: PubMed
    Score: 0.075
  32. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg. 2006 Jun; 141(6):537-43; discussion 543-4.
    View in: PubMed
    Score: 0.072
  33. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006 May 01; 24(13):2065-72.
    View in: PubMed
    Score: 0.072
  34. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol. 2006 May; 13(5):712-20.
    View in: PubMed
    Score: 0.071
  35. Accuracy of preoperative imaging of hepatic tumors with helical computed tomography. Ann Surg Oncol. 2006 Apr; 13(4):542-6.
    View in: PubMed
    Score: 0.071
  36. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg. 2006 Feb; 10(2):240-8.
    View in: PubMed
    Score: 0.071
  37. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg. 2006 Jan; 10(1):86-94.
    View in: PubMed
    Score: 0.070
  38. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol. 2005 Aug; 12(8):616-28.
    View in: PubMed
    Score: 0.068
  39. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005 May; 241(5):715-22, discussion 722-4.
    View in: PubMed
    Score: 0.067
  40. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery. 2005 Apr; 137(4):403-10.
    View in: PubMed
    Score: 0.067
  41. Transdiaphragmatic radiofrequency ablation of liver tumors. J Am Coll Surg. 2004 Nov; 199(5):826-9.
    View in: PubMed
    Score: 0.065
  42. Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. J Gastrointest Surg. 2004 Nov; 8(7):794-804; discussion 804-5.
    View in: PubMed
    Score: 0.065
  43. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol. 2004 Sep; 11(9):869-74.
    View in: PubMed
    Score: 0.064
  44. Critical evaluation of the different staging systems for hepatocellular carcinoma (Br J Surg 2004; 91: 400-408). Br J Surg. 2004 Aug; 91(8):1072.
    View in: PubMed
    Score: 0.064
  45. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004 Jun; 239(6):818-25; discussion 825-7.
    View in: PubMed
    Score: 0.063
  46. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004 Apr; 239(4):450-8.
    View in: PubMed
    Score: 0.062
  47. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg. 2003 Dec; 7(8):1082-8.
    View in: PubMed
    Score: 0.061
  48. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg. 2003 Nov; 238(5):711-9.
    View in: PubMed
    Score: 0.061
  49. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg. 2002 May; 235(5):722-30; discussion 730-1.
    View in: PubMed
    Score: 0.055
  50. Simplified staging for hepatocellular carcinoma. J Clin Oncol. 2002 Mar 15; 20(6):1527-36.
    View in: PubMed
    Score: 0.054
  51. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg. 2002 Mar-Apr; 6(2):224-32; discussion 232.
    View in: PubMed
    Score: 0.054
  52. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma. J Natl Cancer Inst. 2014 May 09; 106(5).
    View in: PubMed
    Score: 0.031
  53. Reassessing hepatocellular carcinoma staging in a changing patient population. Oncology. 2014; 86(2):63-71.
    View in: PubMed
    Score: 0.031
  54. Molecular characterization of gallbladder cancer using somatic mutation profiling. Hum Pathol. 2014 Apr; 45(4):701-8.
    View in: PubMed
    Score: 0.030
  55. Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma. Oncology. 2013; 85(4):197-203.
    View in: PubMed
    Score: 0.030
  56. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford). 2014 May; 16(5):459-68.
    View in: PubMed
    Score: 0.030
  57. Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford). 2013 Oct; 15(10):773-80.
    View in: PubMed
    Score: 0.030
  58. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg. 2013 Jul; 217(1):126-33; discussion 133-4.
    View in: PubMed
    Score: 0.029
  59. Gastric bleeding after radiation therapy for intrahepatic cholangiocarcinoma. Pract Radiat Oncol. 2013 Oct-Dec; 3(4):344-8.
    View in: PubMed
    Score: 0.028
  60. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg. 2013 Jan; 17(1):66-77; discussion p.77.
    View in: PubMed
    Score: 0.028
  61. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.
    View in: PubMed
    Score: 0.028
  62. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford). 2012 Aug; 14(8):506-13.
    View in: PubMed
    Score: 0.027
  63. Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome. Surgery. 2012 Jun; 151(6):851-9.
    View in: PubMed
    Score: 0.027
  64. Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology. 2011 Nov; 141(5):1728-37.
    View in: PubMed
    Score: 0.026
  65. Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. J Am Coll Surg. 2011 Jul; 213(1):62-9; discussion 69-71.
    View in: PubMed
    Score: 0.026
  66. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg. 2010 Jun; 210(6):934-41.
    View in: PubMed
    Score: 0.024
  67. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009 Dec 02; 302(21):2338-44.
    View in: PubMed
    Score: 0.023
  68. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009 Oct; 250(4):540-8.
    View in: PubMed
    Score: 0.023
  69. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology. 2009 May; 49(5):1563-70.
    View in: PubMed
    Score: 0.022
  70. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009 Apr; 7(4):350-91.
    View in: PubMed
    Score: 0.022
  71. The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol. 2009 Feb; 50(2):334-41.
    View in: PubMed
    Score: 0.021
  72. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer. 2008 Oct 15; 123(8):1883-91.
    View in: PubMed
    Score: 0.021
  73. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol. 2008 Nov 10; 26(32):5254-60.
    View in: PubMed
    Score: 0.021
  74. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg. 2007 Nov; 11(11):1498-504; discussion 1504-5.
    View in: PubMed
    Score: 0.020
  75. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis. Ann Surg Oncol. 2007 Oct; 14(10):2807-16.
    View in: PubMed
    Score: 0.019
  76. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol. 2007 May; 188(5):1307-12.
    View in: PubMed
    Score: 0.019
  77. Hepatobiliary cancers. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006 Sep; 4(8):728-50.
    View in: PubMed
    Score: 0.018
  78. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006 May; 141(5):460-6; discussion 466-7.
    View in: PubMed
    Score: 0.018
  79. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum. 2006 Feb; 49(2):175-82.
    View in: PubMed
    Score: 0.018
  80. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol. 2005 Oct 01; 23(28):7125-34.
    View in: PubMed
    Score: 0.017
  81. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg. 2005 May; 140(5):450-7; discussion 457-8.
    View in: PubMed
    Score: 0.017
  82. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol. 2005 May; 12(5):364-73.
    View in: PubMed
    Score: 0.017
  83. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer. 2004 Aug 01; 101(3):578-86.
    View in: PubMed
    Score: 0.016
  84. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg. 2004 Jan; 8(1):56-62; discussion 62-3.
    View in: PubMed
    Score: 0.015
  85. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Ann Surg Oncol. 2003 May; 10(4):348-54.
    View in: PubMed
    Score: 0.015
  86. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol. 2003 Feb 01; 21(3):421-7.
    View in: PubMed
    Score: 0.014
  87. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer. 2003 Jan 15; 97(2):517-24.
    View in: PubMed
    Score: 0.014
  88. A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist. 2003; 8(3):241-51.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.